EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $293 | -6.1% | 10,319 | -3.4% | 0.00% | 0.0% |
| Q4 2022 | $312 | -99.9% | 10,681 | -2.8% | 0.00% | 0.0% |
| Q3 2022 | $290,000 | -40.6% | 10,986 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $488,000 | +6.6% | 10,979 | +18.7% | 0.00% | 0.0% |
| Q1 2022 | $458,000 | -2.8% | 9,251 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $471,000 | -9.4% | 9,248 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $520,000 | +27.5% | 9,316 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $408,000 | +2.5% | 9,538 | +0.1% | 0.00% | 0.0% |
| Q1 2021 | $398,000 | -11.0% | 9,526 | -0.8% | 0.00% | 0.0% |
| Q4 2020 | $447,000 | +4.7% | 9,599 | -4.4% | 0.00% | 0.0% |
| Q3 2020 | $427,000 | +4.9% | 10,042 | +18.4% | 0.00% | 0.0% |
| Q2 2020 | $407,000 | +4.4% | 8,479 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $390,000 | -19.4% | 8,479 | +5.3% | 0.00% | 0.0% |
| Q4 2019 | $484,000 | +6.4% | 8,055 | +0.2% | 0.00% | 0.0% |
| Q3 2019 | $455,000 | +1.1% | 8,036 | -0.6% | 0.00% | 0.0% |
| Q2 2019 | $450,000 | +6.1% | 8,084 | -3.7% | 0.00% | 0.0% |
| Q1 2019 | $424,000 | +36.3% | 8,398 | +8.7% | 0.00% | 0.0% |
| Q4 2018 | $311,000 | -40.6% | 7,725 | +2.2% | 0.00% | -50.0% |
| Q3 2018 | $524,000 | +21.3% | 7,556 | +32.4% | 0.00% | +100.0% |
| Q2 2018 | $432,000 | +53.2% | 5,709 | +6.8% | 0.00% | 0.0% |
| Q1 2018 | $282,000 | -0.7% | 5,347 | +0.6% | 0.00% | 0.0% |
| Q4 2017 | $284,000 | -8.7% | 5,315 | +2.0% | 0.00% | 0.0% |
| Q3 2017 | $311,000 | -99.5% | 5,210 | -99.4% | 0.00% | -99.6% |
| Q2 2017 | $65,386,000 | +17016.8% | 828,820 | +17917.8% | 0.27% | +13450.0% |
| Q1 2017 | $382,000 | +14.7% | 4,600 | +9.5% | 0.00% | +100.0% |
| Q4 2016 | $333,000 | +14.8% | 4,200 | +1.4% | 0.00% | 0.0% |
| Q3 2016 | $290,000 | – | 4,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |